Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ayotunde Omoz-Oarhe, M.B.,B.S.

Concepts (87)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ayotunde Omoz-Oarhe's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ayotunde Omoz-Oarhe has written about over time.
Tuberculosis, Pulmonary, 2 publications between 2013 and 2022, average publication date October 2017. Contraceptive Agents, Female, 1 publications between 2020 and 2020, average publication date July 2020. Latent Tuberculosis, 2 publications between 2019 and 2022, average publication date October 2020. Rifampin, 5 publications between 2019 and 2022, average publication date June 2021. Tuberculosis, 5 publications between 2019 and 2024, average publication date August 2021. HIV Infections, 11 publications between 2013 and 2025, average publication date October 2021. Antitubercular Agents, 5 publications between 2019 and 2024, average publication date October 2021. Isoniazid, 5 publications between 2019 and 2024, average publication date October 2021. Anti-HIV Agents, 3 publications between 2021 and 2024, average publication date August 2022. Alphapapillomavirus, 1 publications between 2022 and 2022, average publication date October 2022. Uterine Cervical Dysplasia, 1 publications between 2022 and 2022, average publication date October 2022. Benzoxazines, 3 publications between 2022 and 2024, average publication date February 2023. Anti-Retroviral Agents, 2 publications between 2022 and 2023, average publication date April 2023. Acquired Immunodeficiency Syndrome, 2 publications between 2022 and 2023, average publication date May 2023. Pregnancy Complications, Infectious, 2 publications between 2023 and 2024, average publication date May 2024. Abortion, Spontaneous, 2 publications between 2024 and 2024, average publication date June 2024. Adjuvants, Immunologic, 1 publications between 2025 and 2025, average publication date January 2025. Hepatitis B, 1 publications between 2025 and 2025, average publication date January 2025. Hepatitis B Vaccines, 1 publications between 2025 and 2025, average publication date January 2025.

To see the data from this visualization as text, click here.
Omoz-Oarhe's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (87)
Explore
_
Co-Authors (5)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.